BRIEF-Puma Biotechnology provides update on review of marketing authorisation application for PB272 – Reuters

March 1 Puma Biotechnology Inc:

* Puma Biotechnology provides update on review of marketing authorisation application for PB272

* Puma Biotechnology Inc - company plans to modify summary of product characteristics in its marketing authorisation application

* Puma Biotechnology-plans to modify summary of product characteristics based on meeting with rapporteur, co-rapporteur, review team members, EMA

* Puma Biotechnology - proposed summary of product characteristics will continue to include both hormone receptor positive, hormone receptor negative patients

* Puma-Will be revising proposed smpc for neratinib to restrict intended population to patients within a year after completion of Adjuvant Trastuzumab Therapy

* Puma-Committee for medicinal products for human use continuing to review co's maa and has not yet made a final decision to recommend approval of drug Source text for Eikon: Further company coverage:

TOKYO, March 2 The dollar hovered near a seven-week high on Thursday on increasing signs given by Federal Reserve officials that the U.S. central bank is seriously considering raising interest rates this month.

* Trump rhetoric deters cenbank from forex intervention -source

RIO DE JANEIRO, March 1 Rio's premier Portela samba school was crowned champion samba school on Wednesday, winning its first Carnival parade in 33 years with a spectacular performance that highlighted the environmental importance of rivers.

Go here to see the original:
BRIEF-Puma Biotechnology provides update on review of marketing authorisation application for PB272 - Reuters